Sanofi S.A.
Explore Sanofi
Core profile pages, annual revenue records, and related research hubs for this company.
Sanofi S.A.
Explore Sanofi
Core profile pages, annual revenue records, and related research hubs for this company.
Business Model Analysis
Annual Revenue: EUR43.63B
Sanofi makes money by discovering, developing, manufacturing, and selling prescription medicines and vaccines through direct sales teams, hospital channels, wholesalers, pharmacies, and government procurement programs. Major revenue drivers include specialty medicines such as Dupixent, rare disease therapies, vaccines, and established general medicines.
The growth strategy centers on immunology, rare diseases, vaccines, pipeline productivity, selective business development, and a sharper focus after the Opella consumer-health separation path.
Sanofi had 74,846 employees as of December 31, 2025.
Sanofi makes money from prescription medicines, vaccines, rare disease therapies, and general medicines sold through health systems, pharmacies, wholesalers, and government procurement programs.
Sanofi competes with Roche, Novartis, Pfizer, AstraZeneca, GSK, Merck, Johnson & Johnson.
The biggest risk is that pricing pressure, patent competition, or R&D setbacks slow growth from Sanofi's core medicines and vaccines.